Filed before 2025Filed 27 June 2016
Verax Biomedical Inc has sold $12.6M so far
Verax Biomedical Inc, a biotech company based in Marlborough, MA, has sold $12.6M so far in its equity round, according to a filing dated 27 June 2016.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 27 June 2016
- First filed
- 2 March 2016
- Round
- Equity round (amended filing)
- Amount sold
- $12.6M
- Offering size
- $24.5M
- Investors so far
- 64
- Based in
- Marlborough, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 74% of the 1,506 tracked raises with an amount filed in 2016, and than 66% of the 120 in biotech.
Verax Biomedical Inc in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 19 Sep 2019 | New filing | $2.54M | Another raise |
| 13 Nov 2017 | New filing | $11.4M | Another raise |
| 27 Jun 2016 | Amended filing | $12.6M | This raise |
| 2 Mar 2016 | New filing | $12.6M | This raise |
| 21 Jan 2015 | New filing | $4M | Another raise |
More with BioVentures on the board
- Hydrocision Inc$2.53M
- General Fluidics Corp$18.5M
- Oncoheroes Biosciences Inc.$8.85M
- Brainbox Solutions, Inc.$18.9M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.